| 53.01 0 (0%) | 05-15 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 61.91 | 1-year : | 72.31 |
| Resists | First : | 53 | Second : | 61.91 |
| Pivot price | 52.91  |
|||
| Supports | First : | 52.71 |
Second : | 52.52 |
| MAs | MA(5) : | 52.97 |
MA(20) : | 52.87 |
| MA(100) : | 43.89 |
MA(250) : | 58.2  |
|
| MACD | MACD : | 1.5 |
Signal : | 2 |
| %K %D | K(14,3) : | 100 |
D(3) : | 95.6 |
| RSI | RSI(14): 77.6 | |||
| 52-week | High : | 90.31 | Low : | 29.43 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ SLNO ] has closed below upper band by 17.8%. Bollinger Bands are 96.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 16 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 53.04 - 53.31 | 53.31 - 53.52 |
| Low: | 52.36 - 52.66 | 52.66 - 52.88 |
| Close: | 52.55 - 53.04 | 53.04 - 53.41 |
Soleno Therapeutics, Inc. (SLNO) operates as a clinical-stage biopharmaceutical company, specializing in the creation and market introduction of groundbreaking treatments for uncommon illnesses. The cornerstone of its therapeutic pipeline is Diazoxide Choline Controlled-Release, a once-daily oral tablet aimed at addressing Prader-Willi Syndrome, currently progressing through an active Phase III clinical evaluation. Established in 1999, the Redwood City, California-headquartered firm adopted its current name, Soleno Therapeutics, Inc., in May 2017, having previously operated as Capnia, Inc.
Wed, 08 Jul 2026
Soleno Therapeutics (SLNO) Cantor Global Healthcare Conference 2025 Summary - Quartr
Fri, 01 May 2026
Soleno Therapeutics (SLNO) Surges Nearly 60% In April Amid Neurocrine Acquisition Deal - Yahoo Finance
Thu, 09 Apr 2026
SOLENO THERAPEUTICS, INC. (SLNO) DEADLINE ALERT Bernstein - GlobeNewswire
Wed, 08 Apr 2026
INVESTOR ALERT: Soleno Therapeutics Inc. (SLNO) Investors - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 52 (M) |
| Shares Float | 51 (M) |
| Held by Insiders | 1.3 (%) |
| Held by Institutions | 111.5 (%) |
| Shares Short | 6,530 (K) |
| Shares Short P.Month | 8,450 (K) |
| EPS | 1.92 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.6 |
| Profit Margin | 33.7 % |
| Operating Margin | 33.5 % |
| Return on Assets (ttm) | 12 % |
| Return on Equity (ttm) | 26.3 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 5.39 |
| Sales Per Share | 5.46 |
| EBITDA (p.s.) | 1.75 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 106 (M) |
| Levered Free Cash Flow | 92 (M) |
| PE Ratio | 27.46 |
| PEG Ratio | 0 |
| Price to Book value | 6.15 |
| Price to Sales | 9.69 |
| Price to Cash Flow | 26.18 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|